D
Doctolib
Transforming healthcare through technology
Knowledge graph
Market map
Rare Disease Therapeutics & Technologies Landscape
Market map
600+ Global VC backed Precision Medicine startups
Market map
Healthy ageing (silver health, elderly care, longevity) Europe
Unicorn list
Health Tech & Medtech unicorns
Unicorn list
Unicorns in France
Analysis
European health companies to watch in 2026
Oct 7, 2026
Analysis
The Doctolib Mafia
May 12, 2026
Open roles
Doctolib in the Levallois-Perret ecosystem
The Doctolib office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
- OOOlivier Occelli
Agoranov- KVKerala Ventures
- BJBertrand Jelensperger
Series A1 investor entered at this stage
- PKPierre Kosciusko-Morizet
Series B and later7 investors entered at this stage
- LKLudwig Klitzsch
Bpifrance
General Atlantic
Eurazeo
Accel- KEKernel
- NBNicolas Brusson
Ownership
Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (Jan/2026). Percentages are indicative.
Some investors are hidden on this public profile. See the full cap table on Dealroom →
Source: Dealroom Talent Intelligence.
Alumni founders
Former Doctolib employees who went on to found companies, sorted by Dealroom signal score.
Alain DuruyFrance
Kevin ValensiFrance
Franck TetzlaffFrance
Matthieu KernFrance
Morgan RouxFranceInvestments and acquisitions
Disclosed deals where Doctolib was the backer or acquirer, 2016–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
7 deals across Doctolib's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Doctolib's portfolio, mapped.
See Doctolib on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
Nvidia pledges $2B more for its European AI push, including a new stake in France's Doctolib